Dose-ranging pilot randomized trial of amino acid mixture combined with physical activity promotion for reducing abdominal fat in overweight adults

Hiroyuki Sasai1 Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki;2 Japan Society for the Promotion of Science, Chiyoda, Tokyo;3 Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Meguro, Tokyo

Keisuke Ueda4 Food Science Research Laboratories, Meiji Co., Ltd., Odawara, Kanagawa;5 Graduate School of Comprehensive Human Sciences

Takehiko Tsujimoto6 Faculty of Health and Sport Sciences, University of Tsukuba, Tsukuba, Ibaraki;7 Faculty of Human Sciences, Shimane University, Matsue, Shimane, Japan

Hiroyuki Kobayashi1 Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki

Chiaki Sanbongi4 Food Science Research Laboratories, Meiji Co., Ltd., Odawara, Kanagawa

Shuji Ikegami4 Food Science Research Laboratories, Meiji Co., Ltd., Odawara, Kanagawa

Yoshio Nakata1 Faculty of Medicine, University of Tsukuba, Tsukuba, IbarakiCorrespondence[email protected]

show all

Dose-ranging pilot randomized trial of amino acid mixture combined with physical activity promotion for reducing abdominal fat in overweight adults

Table 1 Baseline participant characteristics

Table 2 Intention-to-treat analyses for primary, secondary, and compliance outcomes (n=35)

Table S1 Per-protocol-based analyses for primary, secondary, and compliance outcomes (n=28)

Table S2 Adverse events identified by participant’s diary logs (n=35)

Table S3 Adverse events identified during the study period by blood pressure recordings and fasting blood test (n=35)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Dose-ranging pilot randomized trial of amino acid mixture combined with physical activity promotion for reducing abdominal fat in overweight adults

Figures & data

Table 1 Baseline participant characteristics

Table 2 Intention-to-treat analyses for primary, secondary, and compliance outcomes (n=35)

Table S1 Per-protocol-based analyses for primary, secondary, and compliance outcomes (n=28)

Table S2 Adverse events identified by participant’s diary logs (n=35)

Table S3 Adverse events identified during the study period by blood pressure recordings and fasting blood test (n=35)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date